The advent of laser has brought out a revolution in the study of minute particles. The lasers, especially femtosecond and picosecond lasers, are used in a variety of applications ranging from medicine to manufacturing.
Researches are being conducted worldwide in the laser research and this is found to be a major concern in most of Lithuanian researches.
Lithuanian firms concentrate on the production of lasers and it is estimated that nearly 50% of world’s picosecond lasers and 80% of femtosecond parametric light amplifiers are produced by Lithuanian companies.
The research group of Vilnius University has been making a considerable research in the field of lasers from 1970s. The aim of Fast-Dot (1) project conducted by the Vilnius University was to develop next generation lasers that can help a lot in biomedical applications. The research is a joint venture by the research team of Vilnius and 17 partners from different countries.
Mr. R.Tomasiunas reports that the main focus of the project is to develop next-generation lasers that have higher energy efficiency for performing pump-probe and four-wave mixing applications and hence evasive in nano-surgeries.
Neil Stewart, the Fast-Dot project manager, expressed that the new technology will be useful in the study of quantum dot (QD) materials, especially the effect of gallium arsenide in enabling laser tweezing surgery.
Ekspla, a leading laser manufacturing firm in Lithuania, also focuses on the QD materials in the LAMP (2) project but focus is given here in developing laser technology for producing LED devices that enhance the performance and efficiency of LED displays.
The European Commission has given grant for Cross Trap (3) project, joint venture of Light Conversion, a Lithuanian company and eight international partners. The aim of the project is to develop a laser-based technology that excites molecules to produce light. This will help in the production of systems that can detect pollutants and toxins in the atmosphere.
Vilnius University in association with partners from Romania, Italy, Germany, Estonia, and France is involved in VirtualLife (4) project in developing tools for setting peer-to-peer (P2P) architecture that helps in establishing a virtual world, viable for the development of business and e-commerce.
DEMI (5) is another laser project undertaken by Lithuanian Energy Institute in collaboration with other world partners. The study focuses on developing energy-monitoring and decision-support tools for use in computer-aided design systems. The new system will help 15% of energy savings of the manufacturing industry.
The Ponte (6) project is being done in the field of pharmaceutical research. The project team reports that the aim of the research is to put clinical application of new drugs for patient safety at low cost.
Laser research is also done even in the healthcare industry. The Kaunas University of Technology is involved in offering evidence-based solution for traumatic brain injury (TBI). The TBIcare (7) project undertaken the Kaunas University in collaboration with other international partners is focused on offering new diagnosis and treatment solutions for patients with TBI injury. Over 1.6 million people are reported to have undergone TBI in the European Union and this is found to be increasing at the rate of 21% over the past five years.
The TBIcare (7) develops a software tool that provides innumerous databases. This enables medical practitioners to match patient-related variables with injury-related variables and to arrive at the right treatment procedure.
Kaunas University is also involved in Avert-It (8) project that is solely aimed in tracking blood pressure level of patients who suffer from low blood pressure. The project is involved in designing a bed-side monitoring system that tracks changes in the blood pressure level of the patient and sends alerts to the medical staff for improved patient care.
With novel laser researches being conducted in different fields, Lithuania is expected to bring out new revolution in the laser technology.
Source: http://cordis.europa.eu
Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.